VRML stock forecast
Our latest prediction for Vermillion, Inc.'s stock price was made on the June 28, 2019 when the stock price was at 0.89$.
In the short term (2weeks), VRML's stock price should outperform the market by 6.50%. During that period the price should oscillate between -9.29% and +19.42%.
In the medium term (3months), VRML's stock price should outperform the market by 9.07%. During that period the price should oscillate between -22.54% and +54.36%.Get email alerts
About Vermillion, Inc.
Vermillion, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. The company's bio-analytical solutions helps physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion was founded on December 9, 1993 and is headquartered in Austin, TX.
At the moment the company generates 3M USD in revenues.
On its last earning announcement, the company reported a loss of -0.16$ per share.
The book value per share is 0.16$
Three months stock forecastJune 28, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|